191 related articles for article (PubMed ID: 36417124)
1. Role of CHA
Rordorf R; Iacopino S; Verlato R; Arena G; Tondo C; Molon G; Manfrin M; Rovaris G; Perego GB; Sciarra L; Mantica M; Sacchi R; Pieragnoli P
J Interv Card Electrophysiol; 2023 Aug; 66(5):1193-1200. PubMed ID: 36417124
[TBL] [Abstract][Full Text] [Related]
2. Sex effect on efficacy of pulmonary vein cryoablation in patients with atrial fibrillation: data from the multicenter real-world 1STOP project.
Ricciardi D; Arena G; Verlato R; Iacopino S; Pieragnoli P; Molon G; Manfrin M; Allocca G; Cattafi G; Sirico G; Rovaris G; Sciarra L; Nicolis D; Tondo C
J Interv Card Electrophysiol; 2019 Oct; 56(1):9-18. PubMed ID: 31452001
[TBL] [Abstract][Full Text] [Related]
3. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
4. Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: Clinical outcomes from 1STOP, a multicenter observational project.
Perego GB; Iacopino S; Molon G; Arena G; Verlato R; Pieragnoli P; Curnis A; Allocca G; Nicolis D; Sciarra L; Catanzariti D; Senatore G; Rovaris G; Brasca F; Tondo C;
J Cardiol; 2019 Jul; 74(1):19-26. PubMed ID: 30948185
[TBL] [Abstract][Full Text] [Related]
5. Cryoballoon ablation of atrial fibrillation is effectively feasible without previous imaging of pulmonary vein anatomy: insights from the 1STOP project.
Sagone A; Iacopino S; Pieragnoli P; Arena G; Verlato R; Molon G; Rovaris G; Curnis A; Rauhe W; Lunati M; Senatore G; Landolina M; Allocca G; De Servi S; Tondo C
J Interv Card Electrophysiol; 2019 Sep; 55(3):267-275. PubMed ID: 30607667
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Predictors of Very Late Recurrence of Atrial Fibrillation Following Cryoballoon Pulmonary Vein Isolation.
Musat DL; Milstein NS; Bhatt A; Sichrovsky TC; Preminger MW; Pistilli C; Rozylowicz M; Shaw RE; Mittal S
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008646. PubMed ID: 32703009
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project.
Tondo C; Iacopino S; Pieragnoli P; Molon G; Verlato R; Curnis A; Landolina M; Allocca G; Arena G; Fassini G; Sciarra L; Luzi M; Manfrin M; Padeletti L;
Heart Rhythm; 2018 Mar; 15(3):363-368. PubMed ID: 29107190
[TBL] [Abstract][Full Text] [Related]
8. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
9. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
10. Long-term incidence and predictive factors of thromboembolic events after a cryoballoon ablation for atrial fibrillation.
Hermida A; Zaitouni M; Diouf M; Lallemand PM; Fay F; Buiciuc O; Kubala M; Hermida JS
Int J Cardiol; 2020 Dec; 321():99-103. PubMed ID: 32810541
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of C2HEST Score for Atrial Fibrillation Recurrence Following Successful Cryoballoon Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation.
Levent F; Kanat S; Tutuncu A
Angiology; 2023 Mar; 74(3):273-281. PubMed ID: 35583221
[TBL] [Abstract][Full Text] [Related]
12. Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure: A long-term follow-up analysis.
Fassini G; Gasperetti A; Italiano G; Riva S; Moltrasio M; Dello Russo A; Casella M; Maltagliati A; Tundo F; Majocchi B; Arioli L; Al-Mohani G; Pontone G; Pepi M; Tondo C
Heart Rhythm; 2019 Sep; 16(9):1320-1326. PubMed ID: 30928784
[TBL] [Abstract][Full Text] [Related]
13. CHA2DS2-VASc and SAMe-TT2R2 scores as predictors of recurrence for nonvalvular atrial fibrillation patients on vitamin K antagonists after radiofrequency catheter ablation.
Zhao J; Zhou D; Chen M; Zhuo C; Lin Z; Zheng L; Wang Q
J Cardiovasc Med (Hagerstown); 2020 Mar; 21(3):200-208. PubMed ID: 31977539
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Cryoballoon Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation.
Guhl EN; Siddoway D; Adelstein E; Voigt A; Saba S; Jain SK
J Cardiovasc Electrophysiol; 2016 Apr; 27(4):423-7. PubMed ID: 26757058
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
[TBL] [Abstract][Full Text] [Related]
16. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.
Shaikh AY; Esa N; Martin-Doyle W; Kinno M; Nieto I; Floyd KC; Browning C; Ennis C; Donahue JK; Rosenthal LS; McManus DD
Crit Pathw Cardiol; 2015 Dec; 14(4):157-65. PubMed ID: 26569657
[TBL] [Abstract][Full Text] [Related]
17. Predictors of arrhythmia recurrence after balloon cryoablation of atrial fibrillation: the value of CAAP-AF risk scoring system.
Sanhoury M; Moltrasio M; Tundo F; Riva S; Dello Russo A; Casella M; Tondo C; Fassini G
J Interv Card Electrophysiol; 2017 Aug; 49(2):129-135. PubMed ID: 28417287
[TBL] [Abstract][Full Text] [Related]
18. Incorporating coronary calcification by computed tomography into CHA2DS2-VASc score: impact on cardiovascular outcomes in patients with atrial fibrillation.
Wang TKM; Chan N; Cremer PC; Kanj M; Baranowski B; Saliba W; Wazni OM; Jaber WA
Europace; 2021 Aug; 23(8):1211-1218. PubMed ID: 33585883
[TBL] [Abstract][Full Text] [Related]
19. Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience.
Aryana A; Baker JH; Espinosa Ginic MA; Pujara DK; Bowers MR; O'Neill PG; Ellenbogen KA; Di Biase L; d'Avila A; Natale A
Heart Rhythm; 2018 Aug; 15(8):1121-1129. PubMed ID: 30060879
[TBL] [Abstract][Full Text] [Related]
20. Association between baseline glycated hemoglobin level and atrial fibrillation recurrence following cryoballoon ablation among patients with and without diabetes.
Chen Z; Zhang R; Zhang X; Xu W
BMC Cardiovasc Disord; 2024 Feb; 24(1):111. PubMed ID: 38365602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
